ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.520,44
0,82%
S&P 500
5.196,40
0,30%
US Dollar vs BRL
5,064
-0,24%
Bitcoin
63.740,02
0,91%
Brent Oil
82,935
-0,65%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. CryoPort Inc (CYRX)

  7. CryoPort Inc (CYRX) Notícias

CYRX

CryoPort (CYRX)

CryoPort Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYRX
DataHoraFonteTítuloCódigoCompanhia
30/04/202409:30PR Newswire (US)Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:CYRXCryoPort Inc
12/03/202417:05PR Newswire (US)Cryoport Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CYRXCryoPort Inc
27/02/202410:30PR Newswire (US)Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024NASDAQ:CYRXCryoPort Inc
15/02/202418:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYRXCryoPort Inc
14/02/202414:22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CYRXCryoPort Inc
26/01/202418:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CYRXCryoPort Inc
21/12/202318:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CYRXCryoPort Inc
20/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CYRXCryoPort Inc
18/12/202321:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
15/12/202319:09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CYRXCryoPort Inc
15/12/202319:05Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:CYRXCryoPort Inc
11/12/202319:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYRXCryoPort Inc
27/11/202310:30PR Newswire (US)Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain ServicesNASDAQ:CYRXCryoPort Inc
16/11/202310:30PR Newswire (US)Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird ExpressNASDAQ:CYRXCryoPort Inc
09/11/202316:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYRXCryoPort Inc
08/11/202318:05PR Newswire (US)Cryoport Reports Third Quarter 2023 Financial ResultsNASDAQ:CYRXCryoPort Inc
02/11/202309:30PR Newswire (US)Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH AcquisitionNASDAQ:CYRXCryoPort Inc
25/10/202309:30PR Newswire (US)Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:CYRXCryoPort Inc
12/10/202309:30PR Newswire (US)Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVFNASDAQ:CYRXCryoPort Inc
10/10/202309:30PR Newswire (US)Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesNASDAQ:CYRXCryoPort Inc
09/10/202317:05PR Newswire (US)Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene TherapiesNASDAQ:CYRXCryoPort Inc
14/09/202309:30PR Newswire (US)Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence AwardNASDAQ:CYRXCryoPort Inc
09/08/202317:05PR Newswire (US)Cryoport Reports Second Quarter 2023 Financial ResultsNASDAQ:CYRXCryoPort Inc
02/08/202309:30PR Newswire (US)Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:CYRXCryoPort Inc
12/07/202317:05PR Newswire (US)Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue ExpectationsNASDAQ:CYRXCryoPort Inc
29/06/202309:39PR Newswire (US)IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions ProviderNASDAQ:CYRXCryoPort Inc
30/05/202318:20Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:CYRXCryoPort Inc
16/05/202320:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYRXCryoPort Inc
11/05/202317:20Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CYRXCryoPort Inc
04/05/202318:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYRXCryoPort Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
NGRD3
Neogrid Participacoes ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
OIBR3
OI ON
BOV
BRKM5
BRASKEM PNA
BOV
IRBR3
IRB BRASIL ON
BOV
PRIO3
PETRORIO ON
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
MNPR3
MINUPAR ON
BOV
COGN3
COGNA ON
BOV
TELB4
TELEBRAS PN
BOV
GOLL4
GOL PN
BOV
ENAT3
ENAUTA ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
GPIV33
Gp Investments
BOV
PDGR3
PDG REALT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados